Prosecution Insights
Last updated: October 02, 2026

Examiner: STRANSKY, KATRINA MARIE

Tech Center 3700 • Art Units: 3700 3731 3734 3771 3772 3774 3792

This examiner grants 74% of resolved cases

Analysis

Katrina Marie Stransky works in Tech Center 3700 and Art Unit 3700. She has a high volume of experience with 605 resolved cases. Her allowance rate of 74.2 percent indicates a favorable environment for applicants, as a large majority of the cases she resolves result in a patent grant. This 74.2 percent rate suggests a pragmatic approach to examination and a willingness to find allowable subject matter.

Interviews are a beneficial component of prosecution with Stransky, as evidenced by her 24.5 percent interview lift. This metric shows that direct dialogue with the examiner can effectively resolve outstanding issues and move a case toward allowance. For practitioners, this 24.5 percent lift justifies the time and expense of preparing for and conducting an interview to clarify technical points or claim interpretations.

The median days to allowance for Stransky is 1148. This timeline is relatively efficient compared to many other examiners with similar caseloads. Applicants can expect a grant in an expected timeframe if their application is successful. The combination of the high allowance rate and the 1148-day median pendency makes her docket a relatively predictable and productive environment for patent prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

74.2%
Allow Rate
+4.2% vs TC avg
610
Total Applications
+24.5%
Interview Lift
1148
Avg Prosecution Days
Based on 605 resolved cases, 2023–2026

Rejection Statute Breakdown

1.4%
§101 Eligibility
26.6%
§102 Novelty
44.0%
§103 Obviousness
20.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18663772 Inflatable Prosthesis, Delivery Tools Therefor, Implantation Method Therefor, And Manufacturing Method Therefor Non-Final OA Stryker Corporation
18897752 MULTIFOCAL OPHTHALMIC LENSES Non-Final OA Alcon Inc.
18827056 FLEXIBLE VALVE ANCHORS Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18758424 ENCLOSURE FOR MITIGATION OF LEAKAGE BY SYRINGE ASSEMBLY Non-Final OA Merck Sharp & Dohme LLC
18131918 MEDICAL DEVICE SUPPORT DEVICES Final Rejection ABIOMED, Inc.
18384435 PLATE ASSEMBLY FOR TISSUE COMPRESSION SYSTEM AND CORRESPONDING METHOD Non-Final OA Arthrex, Inc.
18844860 MEDICATION DELIVERY DEVICE Non-Final OA Becton, Dickinson and Company
18890209 CATHETER ASSEMBLY AND BLOOD VESSEL PUNCTURE SYSTEM Non-Final OA TERUMO KABUSHIKI KAISHA
18771573 GASKET FOR USE IN SYRINGE AND SYRINGE INCLUDING SAME Non-Final OA TERUMO KABUSHIKI KAISHA
18612628 DILATOR AND DUAL WIRE LUMEN SYSTEMS Final Rejection Merit Medical Systems, Inc.
18853104 MIXER FOR MIXING AND DISPENSING AT LEAST TWO COMPONENTS Non-Final OA medmix Switzerland AG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month